Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.

The sterol sensor SCAP is a key regulator of SREBP-2, the major transcription factor controlling cholesterol synthesis. Recently, we showed that there is a global down-regulation of cholesterol synthetic genes, as well as SREBP-2, in the brains of diabetic mice, leading to a reduction of cholesterol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ryo Suzuki, Heather A Ferris, Melissa J Chee, Eleftheria Maratos-Flier, C Ronald Kahn
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/20626864efbe41f48c6aed40649860c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:20626864efbe41f48c6aed40649860c6
record_format dspace
spelling oai:doaj.org-article:20626864efbe41f48c6aed40649860c62021-11-18T05:37:10ZReduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.1544-91731545-788510.1371/journal.pbio.1001532https://doaj.org/article/20626864efbe41f48c6aed40649860c62013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23585733/?tool=EBIhttps://doaj.org/toc/1544-9173https://doaj.org/toc/1545-7885The sterol sensor SCAP is a key regulator of SREBP-2, the major transcription factor controlling cholesterol synthesis. Recently, we showed that there is a global down-regulation of cholesterol synthetic genes, as well as SREBP-2, in the brains of diabetic mice, leading to a reduction of cholesterol synthesis. We now show that in mouse models of type 1 and type 2 diabetes, this is, in part, the result of a decrease of SCAP. Homozygous disruption of the Scap gene in the brains of mice causes perinatal lethality associated with microcephaly and gliosis. Mice with haploinsufficiency of Scap in the brain show a 60% reduction of SCAP protein and ~30% reduction in brain cholesterol synthesis, similar to what is observed in diabetic mice. This results in impaired synaptic transmission, as measured by decreased paired pulse facilitation and long-term potentiation, and is associated with behavioral and cognitive changes. Thus, reduction of SCAP and the consequent suppression of cholesterol synthesis in the brain may play an important role in the increased rates of cognitive decline and Alzheimer disease observed in diabetic states.Ryo SuzukiHeather A FerrisMelissa J CheeEleftheria Maratos-FlierC Ronald KahnPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Biology, Vol 11, Iss 4, p e1001532 (2013)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Ryo Suzuki
Heather A Ferris
Melissa J Chee
Eleftheria Maratos-Flier
C Ronald Kahn
Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.
description The sterol sensor SCAP is a key regulator of SREBP-2, the major transcription factor controlling cholesterol synthesis. Recently, we showed that there is a global down-regulation of cholesterol synthetic genes, as well as SREBP-2, in the brains of diabetic mice, leading to a reduction of cholesterol synthesis. We now show that in mouse models of type 1 and type 2 diabetes, this is, in part, the result of a decrease of SCAP. Homozygous disruption of the Scap gene in the brains of mice causes perinatal lethality associated with microcephaly and gliosis. Mice with haploinsufficiency of Scap in the brain show a 60% reduction of SCAP protein and ~30% reduction in brain cholesterol synthesis, similar to what is observed in diabetic mice. This results in impaired synaptic transmission, as measured by decreased paired pulse facilitation and long-term potentiation, and is associated with behavioral and cognitive changes. Thus, reduction of SCAP and the consequent suppression of cholesterol synthesis in the brain may play an important role in the increased rates of cognitive decline and Alzheimer disease observed in diabetic states.
format article
author Ryo Suzuki
Heather A Ferris
Melissa J Chee
Eleftheria Maratos-Flier
C Ronald Kahn
author_facet Ryo Suzuki
Heather A Ferris
Melissa J Chee
Eleftheria Maratos-Flier
C Ronald Kahn
author_sort Ryo Suzuki
title Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.
title_short Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.
title_full Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.
title_fullStr Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.
title_full_unstemmed Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function.
title_sort reduction of the cholesterol sensor scap in the brains of mice causes impaired synaptic transmission and altered cognitive function.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/20626864efbe41f48c6aed40649860c6
work_keys_str_mv AT ryosuzuki reductionofthecholesterolsensorscapinthebrainsofmicecausesimpairedsynaptictransmissionandalteredcognitivefunction
AT heatheraferris reductionofthecholesterolsensorscapinthebrainsofmicecausesimpairedsynaptictransmissionandalteredcognitivefunction
AT melissajchee reductionofthecholesterolsensorscapinthebrainsofmicecausesimpairedsynaptictransmissionandalteredcognitivefunction
AT eleftheriamaratosflier reductionofthecholesterolsensorscapinthebrainsofmicecausesimpairedsynaptictransmissionandalteredcognitivefunction
AT cronaldkahn reductionofthecholesterolsensorscapinthebrainsofmicecausesimpairedsynaptictransmissionandalteredcognitivefunction
_version_ 1718424837559418880